Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guojun Liang

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Molecules (Basel, Switzerland)|December 23, 2022
Regulating the Electronic Structure of Freestanding Graphene on SiC by Ge/Sn Intercalation: A Theoretical StudyXingyun Luo, Guojun Liang, Yanlu Li, et al.
Frontiers in Pharmacology|April 3, 2026
Post-marketing safety profile of meningococcal group B vaccines: a real-world disproportionality analysis of the VAERS database, 2015Q1-2025Q3Guojun Liang, Hao Huang, Jihui Huang, et al.
Sexual Health|July 5, 2026
Flibanserin safety in real-world use: a decade of US Food and Drug Administration Adverse Event Reporting System pharmacovigilance evidenceGuojun Liang, Hao Huang, Haokui Wang, et al.
IEEE Transactions on Neural Networks and Learning Systems|July 9, 2024
Dynamic Causal Explanation Based Diffusion-Variational Graph Neural Network for Spatiotemporal ForecastingGuojun Liang, Prayag Tiwari, Slawomir Nowaczyk, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 29, 2014
MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathwayYongqiang Dong, Guojun Liang, Bo Yuan, et al.
Oncology Reports|December 23, 2014
Nucleosome-binding protein HMGN2 exhibits antitumor activity in human SaO2 and U2-OS osteosarcoma cell linesGuojun Liang, Enjie Xu, Chaoqun Yang, et al.
Pharmacology Research & Perspectives|November 17, 2025
A Real-World Disproportionality Analysis of Avacopan in Anti-Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting SystemGuojun Liang, Xiaofang Liu, Mengge Gao, et al.
Oncology Reports|October 18, 2024
[Corrigendum] Nucleosome‑binding protein HMGN2 exhibits antitumor activity in human SaO2 and U2‑OS osteosarcoma cell linesGuojun Liang, Enjie Xu, Chaoqun Yang, et al.
Therapeutic Innovation & Regulatory Science|August 20, 2025
A Real-World Disproportionality Analysis of FDA Adverse Event Reporting System Events for TazemetostatQiong Liu, Miaoqing Luo, Mengge Gao, et al.
AIDS Care|December 14, 2011
Developing and piloting an expert system for better routine voluntary HIV counseling and testing in China: preliminary results and lessonsJing Chai, DeBin Wang, Meng Zhou, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Molecules (Basel, Switzerland)|December 23, 2022
Regulating the Electronic Structure of Freestanding Graphene on SiC by Ge/Sn Intercalation: A Theoretical StudyXingyun Luo, Guojun Liang, Yanlu Li, et al.
Frontiers in Pharmacology|April 3, 2026
Post-marketing safety profile of meningococcal group B vaccines: a real-world disproportionality analysis of the VAERS database, 2015Q1-2025Q3Guojun Liang, Hao Huang, Jihui Huang, et al.
Sexual Health|July 5, 2026
Flibanserin safety in real-world use: a decade of US Food and Drug Administration Adverse Event Reporting System pharmacovigilance evidenceGuojun Liang, Hao Huang, Haokui Wang, et al.
IEEE Transactions on Neural Networks and Learning Systems|July 9, 2024
Dynamic Causal Explanation Based Diffusion-Variational Graph Neural Network for Spatiotemporal ForecastingGuojun Liang, Prayag Tiwari, Slawomir Nowaczyk, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 29, 2014
MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathwayYongqiang Dong, Guojun Liang, Bo Yuan, et al.
Oncology Reports|December 23, 2014
Nucleosome-binding protein HMGN2 exhibits antitumor activity in human SaO2 and U2-OS osteosarcoma cell linesGuojun Liang, Enjie Xu, Chaoqun Yang, et al.
Pharmacology Research & Perspectives|November 17, 2025
A Real-World Disproportionality Analysis of Avacopan in Anti-Neutrophil Cytoplasmic Antibodies Associated Vasculitis: Insights From FDA Adverse Event Reporting SystemGuojun Liang, Xiaofang Liu, Mengge Gao, et al.
Oncology Reports|October 18, 2024
[Corrigendum] Nucleosome‑binding protein HMGN2 exhibits antitumor activity in human SaO2 and U2‑OS osteosarcoma cell linesGuojun Liang, Enjie Xu, Chaoqun Yang, et al.
Therapeutic Innovation & Regulatory Science|August 20, 2025
A Real-World Disproportionality Analysis of FDA Adverse Event Reporting System Events for TazemetostatQiong Liu, Miaoqing Luo, Mengge Gao, et al.
AIDS Care|December 14, 2011
Developing and piloting an expert system for better routine voluntary HIV counseling and testing in China: preliminary results and lessonsJing Chai, DeBin Wang, Meng Zhou, et al.
Pageof 4